Osocimab, CAS 2056878-75-0

Product Description: Osocimab (BAY 1213790), an anti-FXIa antibody (Ki=2.4 nM; EC50=0.2 nM). FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time. Osocimab exhibits anticoagulant effects[1].

Applications: Neuroscience-Neuromodulation

Formula: N/A

References: [1]Schaefer M, et al. Allosteric Inhibition as a New Mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated Form of Coagulation Factor XI. J Mol Biol. 2019 Dec 6;431(24):4817-4833.

CAS Number: 2056878-75-0

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cardiovascular Disease

Solubility: 10 mM in DMSO

Target: Factor Xa

• Artikelnummer: MEXHY-P99794-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99794-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated